Start Free Trial
GlobalGov › Italy › Pharmaceuticals › Solicitation

Italy – Pharmaceutical products – Bando SDA FARMACI EMODERIVATI SOLUZIONI INFUSIONALI VACCINI E MEZZI DI CONTRASTO prima edizione

Gen-Pub · Italy government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

October 01, 2029
Response Due
Active
Status

Opportunity Overview

Italy – Pharmaceutical products – Call for proposals SDA BLOOD DERIVATIVES DRUGS INFUSION SOLUTIONS VACCINES AND CONTRASTING MEDICINES first edition

This is one of 1,889 active Italy Pharmaceuticals opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyGen-Pub
CountryItaly
CategoryPharmaceuticals
PublishedSeptember 30, 2025
Response dueOctober 01, 2029
StatusActive - open for responses
Official sourceView original notice
Italy market overview →Pharmaceuticals tenders in Italy →Browse all categories →

Related Opportunities in Italy

Pharmaceutical Products
Italy – Pharmaceutical products – Istituzione del Sistema Dinamico di Acquisizione per la fornitura di Beni Farmaceutici. Finalizzato alla partecipazione di Appalti specifici per la stipula di Convenzioni/Accordi quadro. Il SDA potrà.
Italy-Benevento: Social work services
Italy-Santeramo in Colle: Social work services with accommodation
Pharmaceutical Products
Italy-Rovigo: Social work services with accommodation
Italy-Villa Castelli: Social work services with accommodation
Italy-Trofarello: Child daycare services

See every Italy Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →